Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ELEGANCE - A Non-interventional Study on Long-term Effectiveness and Safety of Levodopa-Entacapone-Carbidopa Intestinal Gel (Lecigon®) in Patients With Advanced Parkinson's Disease in Routine Care

NCT05043103 is registered in ClinicalTrials.gov with Britannia Pharmaceuticals Ltd. as lead sponsor.

NCT NCT05043103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05043103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ELEGANCE - A Non-interventional Study on Long-term Effectiveness and Safety of Levodopa-Entacapone-Carbidopa Intestinal Gel (Lecigon®) in Patients With Advanced Parkinson's Disease in Routine Care
Lead sponsor
Britannia Pharmaceuticals Ltd.
Phase
Observational
Overall status
Active, not recruiting
Start date
July 6, 2021
Completion date
October 7, 2026
Enrollment
312 (actual)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

advanced parkinson disease